MarketsandMarkets Obama’s Healthcare Reform Bill and Its Impact on the U.S. Healthcare Market (Pharmaceuticals, Medical Devices and Health Insurance)

According to a 2009 study by the World Health Organization, the U.S. healthcare system ranks 37th among the healthcare systems of 200 countries.


Dallas, TX -- (SBWIRE) -- 12/01/2011 -- This report forecasts the future impacts of the Health Reform bill enacted by President Obama in March 2010. The report focuses on the U.S. healthcare system and its major stakeholders such as pharmaceutical manufacturers, medical devices manufacturers, and health insurance industry.

Browse in-depth TOC on Obama’s Healthcare Reform Bill and its impact on the U.S. Healthcare Market. Early buyers will receive 10% customization of reports

The health reform bill set forth several provisions to improve the quality and efficiency of healthcare, address the inefficiencies of the existing healthcare structure, and to decrease the number of uninsured people in the U.S. In order to implement a self-funded reform, the Obama Administration set forward provisions for cost containment and assessment of annual fees (in the form of excise tax) on drug manufacturers, medical device companies, and the private insurance industry over a period of 2010 to 2019. Successful implementation of the health reforms by 2019 would reduce federal budgetary deficit by $143 billion from about $1.4 trillion in 2009.

The industry-specific provisions of the health reforms are expected to have a mixed impact on drug manufacturers and medical device industry.

Evaluating the health reforms from the perspective of changing equation among industry stakeholders, empowerment of consumers in the long run is likely to create a win-win situation for all stakeholders.

The report forecasts and analyzes the future impact of the health reforms on the U.S. healthcare industry. This covers direct as well as indirect impacts of the provisions on pharmaceutical, medical devices, and health insurance industries. Indirect impact refers to provisions that do not specifically apply to these industries. Each section offers a strategic analysis of the impact of Obama’s health reforms on the U.S. healthcare structure.

MarketsandMarkets: Obama’s Healthcare Reform Bill and its impact on the U.S. healthcare market (Pharmaceuticals, Medical devices and health insurance)

About MarketsandMarkets
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.